CrushSCI.com
提供学术论文选刊润色服务
International Immunopharmacology 期刊封面 医学
返回期刊列表

Review Cycle Records

International Immunopharmacology

Elsevier SCIE 非OA
2026新锐 2区2025中科院 2区2025 JCR Q1
157.6平均天数
109.5中位天数
54最短天数
383最长天数
1,9332025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

75 天

FGF21 inhibits atherosclerosis by reducing endothelial ferroptosis via activation of AMPK/Nrf2 signaling

作者Dandan Song; Zhenzhen Chen; Chao Qi; Youyou Yan; Junnan Wang

作者单位Department of Clinical Laboratory, Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, China; Department of Cardiology, Second Hospital of Jilin University, Changchun, Jilin 130041, China; Changbaishan Laboratory, Jilin University, Changchun 130012, China

PDF源文件 DOI 网页
113 天

Isoforskolin targets ADCY7 to restore mitochondrial function in COPD-associated macrophages

作者Zengrui Wang; Rongrong Wu; Shuai jun Li; Xiaorong Su; Yue Yang; Le Wang; Jiefu Tang; Zhuang Luo

作者单位Kunming Medical University, Kunming, Yunnan, China; The First People's Hospital of Yunnan Province, Kunming, Yunnan, China; Tongji University, Shanghai, China

PDF源文件 DOI 网页
121 天

Identifying GSTM1, SDC1, and VTN as key biomarkers and therapeutic targets for NETs in acute pancreatitis based on bioinformatics analysis and experiments

作者Huang Chen; Pingting Huang; Zu-Wei Wang; Tian-Jiao Song

作者单位Fuzhou University Affiliated Provincial Hospital, Fuzhou 350001, China; Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China; Department of Emergency, Fujian Provincial Hospital, Fuzhou 350001, China; Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou 350001, China

PDF源文件 DOI 网页
54 天

QP6126, an orally bioavailable QPCTL inhibitor, with anti-tumor activity in melanoma tumor model

作者Longyan Xie; Zening Zheng; Xindan Zhang; Yaoliang Sun; Siqi Liu; Shilin Xu; Lei Yu

作者单位Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200092, China; Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Science, Beijing 100049, China

PDF源文件 DOI 网页
346 天

Targeted drug delivery of rosuvastatin via nanoemulgel: A step towards more effective rheumatoid arthritis therapy

作者Vrushali Pathade; Shweta Nene; Shreya Ratnam; Kamatham Pushpa Tryphena; Etikala Amulya; Ganesh Vambhurkar; Saurabh Srivastava

作者单位Pharmaceutical Innovation and Translational Research Lab (PITRL), Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India; Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India

PDF源文件 DOI 网页
383 天

Targeting SGK1 mitigates synovial fibrosis via suppressing M1 polarization to alleviate osteoarthritis

作者Zhichao Yang; Wenwei Li; Yang Liu; Ming Wei; Zhaoyu Li; Liang Yan; Zezhong Guo; Yang Lv; Feng Li; Wei Zhou; Wei Huang

作者单位Department of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230022, China; Bengbu Medical University, Bengbu 233000, China; Anhui Medical University, Hefei 230031, China; Anhui University of Science& Technology, Huainan 232001, China; Huaibei People's Hospital, Huaibei 235025, China

PDF源文件 DOI 网页
169 天

Copper exposure disrupts the stability of SAM50-MICOS-ATAD3-mtDNA axis to activate the cGAS–STING and NLRP3 pathway in pig liver

作者Wenyue Qiu; Wei Chen; Hao Xi; Shanglong Yang; Yixin Dai; Zhuoya Zheng; Pengxu Li; Shuhua Zhou; JianZhao Liao; Rongsheng Su; Zhaoxin Tang

作者单位College of Veterinary Medicine, South China of Agricultural University, Guangzhou 510642, China

PDF源文件 DOI 网页
106 天

Targeting the macrophage-NLRP3 inflammasome-pyroptosis axis: Metformin-capped silver nanoparticles as a novel therapy for premature ovarian insufficiency

作者Sifang Feng; Juan Zhao; Peixuan Li; Ting Yang; Long Li

作者单位Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China; Health Science Center, Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China

PDF源文件 DOI 网页
103 天

Discovery of immune-activating molecules targeting TLR7/8 receptors from natural products

作者Yu Wang; Min Yao; Jingyu Wu; Zhuolan Huang; Jianyu Zhao; Yifan Li; Yanwen Li; Panpan Wu; Dongli Li; Lishe Gan; Jingwei Jin

作者单位Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, School of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, PR China; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China

PDF源文件 DOI 网页
106 天

Interleukin-35 attenuates hepatic lipotoxic stress through AMPK-associated metabolic and antioxidative regulation in NAFLD-like models

作者Min Kyung Pyo; Jun Hwi Ko; Do Su Lim; Hyeon Ji Gwon; A.M. Abd El-Aty; Soon Auck Hong; Ji Hoon Jeong; Tae Woo Jung

作者单位Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea; Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, 12211-Giza, Egypt; Department of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum 25240, Turkey; Department of Pathology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。